Senior Vice President, Translational Discovery

Recursion Pharmaceuticals

Passionate about leading teams that bring together the most advancedscience and technology to make an impact on human disease.

Dr. Alfa is Vice President, Discovery and Product at Recursion Pharmaceuticals (recursionpharma.com), an AI-enabled drug discovery company combining state-of-the-art machine learning with automated cell biology. At Recursion, he leads Product across the organization working closely with all teams to leverage computational tools & robotics to solve important drug discovery challenges. He received training in Neurosciences, Medicine, and Entrepreneurship at Stanford University and has made scientific contributions to the fields of Neurosciences, Metabolism, and Genetics. Prior to Recursion, Dr. Alfa worked closely with biotech start-ups at Stanford-affiliated accelerator, StartX.

Latest insights

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Fri Nov 8 2019

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

Never miss an announcement